Inactive Instrument
Cellivery Therapeutics, Inc. Stock
Stocks
A268600
KR7268600004
Biotechnology & Medical Research
| 1 day | -30.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
CEO | Chief Executive Officer | 58 | 2014-08-27 |
Byung-Hwa Lee
AUD | Comptroller/Controller/Auditor | 62 | 2019-03-21 |
| Director | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
BRD | Director/Board Member | 58 | 2014-08-27 |
Yung-Ki Baek
BRD | Director/Board Member | 73 | 2023-03-30 |
Hyung Kim
BRD | Director/Board Member | 40 | 2024-03-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -30.43% | -75.38% | - | - | 400K | |
| -2.11% | -3.44% | +41.04% | +98.48% | 68.24B | |
| -0.23% | -6.42% | +30.19% | +76.15% | 62.23B | |
| +1.70% | +2.23% | -11.44% | +387.21% | 27.8B | |
| -1.05% | -7.30% | +25.00% | +12.31% | 24.86B | |
| +0.48% | -6.58% | -7.07% | -17.82% | 24.22B | |
| +0.43% | -4.78% | +18.26% | -20.61% | 19.36B | |
| -3.03% | -5.19% | +192.88% | +340.13% | 17.28B | |
| -1.94% | -6.36% | -7.05% | +516.16% | 14.46B | |
| -2.27% | -4.42% | +44.36% | +156.49% | 14.23B | |
| Average | -3.82% | -3.96% | +36.24% | +172.06% | 30.3B | |
| Weighted average by Cap. | -0.84% | -3.80% | +33.11% | +136.67% |
Employees
-
